Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
PLoS One ; 12(1): e0170425, 2017.
Article in English | MEDLINE | ID: mdl-28099492

ABSTRACT

Bovine viral diarrhea virus (BVDV) plays a key role in bovine respiratory disease complex, which can lead to pneumonia, diarrhea and death of calves. Current vaccines are not very effective due, in part, to immunosuppressive traits and failure to induce broad protection. There are diverse BVDV strains and thus, current vaccines contain representative genotype 1 and 2 viruses (BVDV-1 & 2) to broaden coverage. BVDV modified live virus (MLV) vaccines are superior to killed virus vaccines, but they are susceptible to neutralization and complement-mediated destruction triggered by passively acquired antibodies, thus limiting their efficacy. We generated three novel mosaic polypeptide chimeras, designated NproE2123; NS231; and NS232, which incorporate protective determinants that are highly conserved among BVDV-1a, 1b, and BVDV-2 genotypes. In addition, strain-specific protective antigens from disparate BVDV strains were included to broaden coverage. We confirmed that adenovirus constructs expressing these antigens were strongly recognized by monoclonal antibodies, polyclonal sera, and IFN-γ-secreting T cells generated against diverse BVDV strains. In a proof-of-concept efficacy study, the multi-antigen proto-type vaccine induced higher, but not significantly different, IFN-γ spot forming cells and T-cell proliferation compared to a commercial MLV vaccine. In regards to the humoral response, the prototype vaccine induced higher BVDV-1 specific neutralizing antibody titers, whereas the MLV vaccine induced higher BVDV-2 specific neutralizing antibody titers. Following BVDV type 2a (1373) challenge, calves immunized with the proto-type or the MLV vaccine had lower clinical scores compared to naïve controls. These results support the hypothesis that a broadly protective subunit vaccine can be generated using mosaic polypeptides that incorporate rationally selected and validated protective determinants from diverse BVDV strains. Furthermore, regarding biosafety of using a live vector in cattle, we showed that recombinant human adenovirus-5 was cleared within one week following intradermal inoculation.


Subject(s)
Antibodies, Neutralizing/blood , Antibodies, Viral/blood , Antigens, Viral/immunology , Bovine Virus Diarrhea-Mucosal Disease/immunology , Cross Protection/immunology , Cross-Priming/immunology , Diarrhea Virus 1, Bovine Viral/immunology , Diarrhea Virus 2, Bovine Viral/immunology , Vaccines, Subunit/immunology , Viral Vaccines/immunology , Animals , Antigens, Viral/genetics , Bovine Virus Diarrhea-Mucosal Disease/virology , Cattle , Cell Line , Chimera/genetics , Chimera/immunology , Diarrhea Virus 1, Bovine Viral/genetics , Diarrhea Virus 2, Bovine Viral/genetics , HEK293 Cells , Humans , Interferon-gamma/immunology , T-Lymphocytes/immunology , Vaccination
2.
Vaccine ; 30(9): 1624-35, 2012 Feb 21.
Article in English | MEDLINE | ID: mdl-22240344

ABSTRACT

Dendritic cell antigen targeting primes robust immune responses in mouse models. Optimizing this immunization strategy in the actual hosts that require protection will advance development of efficacious contemporary vaccines. In a proof-of-concept study, we tested the immunogenicity of a single, low dose of a novel multi-component DNA construct expressing a CD205-targeted antigen fused to a CD40L minimal functional domain for linked DC activation. The DNA construct was formulated with DNA-encoded Flt3L and GM-CSF for DC recruitment and the formulation was evaluated in MHC class II-matched calves. Immunization of the calves with the CD205 antigen-targeting construct mixed with the cytokine constructs induced significant IFN-γ-secreting CD4(+) T-cells, CD4(+) T-cell proliferation, and antibody responses detectable within one week post-immunization. CD205 antigen-targeting significantly expanded IFN-γ-secreting CD4(+) T-cells, CD4(+) T-cell proliferation, and IgG antibody responses three weeks post-immunization. Nineteen weeks post-priming, the IFN-γ-secreting CD4(+) T-cells, CD4(+) T-cell proliferation, and the IgG titers were waning, but they remained significant. Following boosting at nineteen weeks post-immunization, the immune responses primed by the CD205-targeted antigen underwent rapid recall and the mean response tripled within one week post-boost. Comparative analysis of the immune responses observed one week post-priming versus the responses detected one week post-boost revealed that the average number of the IFN-γ-secreting CD4(+) T-cells observed in the calves immunized with the CD205 antigen targeting construct increased five-fold, the mean CD4(+) T-cell proliferation increased three-fold, whereas the mean IgG antibody titer increased two hundred-fold. These promising outcomes support testing the protective efficacy of CD205-targeted antigens in the calf model.


Subject(s)
Antigens, CD/immunology , CD4-Positive T-Lymphocytes/immunology , CD40 Ligand/immunology , Dendritic Cells/immunology , Lectins, C-Type/immunology , Receptors, Cell Surface/immunology , Vaccines, DNA/immunology , Anaplasma marginale/immunology , Animals , Antibody Formation , B-Lymphocytes/immunology , Bacterial Outer Membrane Proteins/immunology , Cattle , Cell Proliferation , Dose-Response Relationship, Immunologic , Granulocyte-Macrophage Colony-Stimulating Factor/immunology , HEK293 Cells , Humans , Immunoglobulin G/blood , Interferon-gamma/immunology , Lymphocyte Activation , Male , Membrane Proteins/immunology , Minor Histocompatibility Antigens
3.
PLoS Negl Trop Dis ; 3(11): e544, 2009 Nov 10.
Article in English | MEDLINE | ID: mdl-19901988

ABSTRACT

Human onchocerciasis, caused by the filarial nematode Onchocerca volvulus, is controlled almost exclusively by the drug ivermectin, which prevents pathology by targeting the microfilariae. However, this reliance on a single control tool has led to interest in vaccination as a potentially complementary strategy. Here, we describe the results of a trial in West Africa to evaluate a multivalent, subunit vaccine for onchocerciasis in the naturally evolved host-parasite relationship of Onchocerca ochengi in cattle. Naïve calves, reared in fly-proof accommodation, were immunised with eight recombinant antigens of O. ochengi, administered separately with either Freund's adjuvant or alum. The selected antigens were orthologues of O. volvulus recombinant proteins that had previously been shown to confer protection against filarial larvae in rodent models and, in some cases, were recognised by serum antibodies from putatively immune humans. The vaccine was highly immunogenic, eliciting a mixed IgG isotype response. Four weeks after the final immunisation, vaccinated and adjuvant-treated control calves were exposed to natural parasite transmission by the blackfly vectors in an area of Cameroon hyperendemic for O. ochengi. After 22 months, all the control animals had patent infections (i.e., microfilaridermia), compared with only 58% of vaccinated cattle (P = 0.015). This study indicates that vaccination to prevent patent infection may be an achievable goal in onchocerciasis, reducing both the pathology and transmissibility of the infection. The cattle model has also demonstrated its utility for preclinical vaccine discovery, although much research will be required to achieve the requisite target product profile of a clinical candidate.


Subject(s)
Antigens, Helminth/administration & dosage , Cattle , Disease Models, Animal , Onchocerca/immunology , Onchocerciasis/prevention & control , Vaccines/administration & dosage , Animals , Antibodies, Helminth/blood , Antibodies, Helminth/immunology , Antigens, Helminth/genetics , Antigens, Helminth/immunology , Female , Humans , Immunoglobulin G/blood , Immunoglobulin G/immunology , Male , Onchocerciasis/blood , Onchocerciasis/immunology , Onchocerciasis/parasitology , Simuliidae , Vaccination , Vaccines/genetics , Vaccines/immunology
4.
J Immunol ; 182(4): 1854-9, 2009 Feb 15.
Article in English | MEDLINE | ID: mdl-19201837

ABSTRACT

Over the last several years, there has been a great deal of progress in characterizing the role of dendritic cells (DCs) in the activation and modulation of B cells. DC-secreted chemokines can induce B cell trafficking to the lymph nodes. DC-produced survival factors such as B cell-activating factor of the TNF family and a proliferation-inducing ligand have been shown to be essential for B cell maturation, but have also been implicated in class-switch recombination and B cell lymphoma survival. Recently added to this list of DC-derived factors effecting B cells is IgA-inducing protein (IGIP). In this study, we characterize production of IGIP by human DCs, and examine its capacity to induce IgA class switching and differentiation of naive B cells in vitro. Monocyte-derived DCs were cultured in vitro with TLR agonists (TLR3, 4, 5, and 9) and other factors, including CD40 ligand, GM-CSF, and IL-4 as well as the neuropeptide vasoactive intestinal peptide. Under in vitro stimulation with vasoactive intestinal peptide and CD40L, IGIP mRNA expression could be up-regulated as much as 35-fold above nonstimulated samples within 12-48 h. Naive B cells cultured with exogenous recombinant human IGIP produced IgA in greater quantities than nonstimulated controls. Finally, we demonstrate that IGIP stimulation drives the production of mu-alpha switch circles from IgM(+)IgD(+) naive human B cells, indicating its role as an IgA switch factor.


Subject(s)
B-Lymphocytes/immunology , Dendritic Cells/immunology , Immunoglobulin A/biosynthesis , Lymphocyte Activation/immunology , Proteins/immunology , B-Lymphocytes/cytology , Cell Differentiation/immunology , Dendritic Cells/metabolism , Enzyme-Linked Immunosorbent Assay , Gene Expression Regulation/immunology , Humans , Immunoglobulin Class Switching/immunology , Immunoglobulin D/immunology , Reverse Transcriptase Polymerase Chain Reaction
5.
Am J Trop Med Hyg ; 76(1): 67-72, 2007 Jan.
Article in English | MEDLINE | ID: mdl-17255232

ABSTRACT

Although vector control and ivermectin chemotherapy have led to a dramatic reduction in the incidence of river blindness (onchocerciasis), there is a consensus that additional control tools are required to sustain and extend this success. The recognition of endosymbiotic bacteria (Wolbachia) in filariae and their targeting by antibiotics constitutes the most significant and practicable opportunity for a macrofilaricidal therapy in the short-to-medium-term. Using Onchocerca ochengi in cattle, an analog of human onchocerciasis, we have previously shown that oxytetracycline is macrofilaricidal, and protective immunity exists naturally in a subset of animals termed putatively immune. Here, we report that although 24 weeks of weekly oxytetracycline treatment eliminated adult worms, cured animals remained susceptible to re-infection by natural challenge when compared with putatively immune cattle. However, their susceptibility was not significantly different from that of concurrently exposed, heavily infected animals. Thus, cattle cured by oxytetracycline are neither hypo-susceptible nor hyper-susceptible.


Subject(s)
Anthelmintics/therapeutic use , Cattle Diseases/drug therapy , Disease Susceptibility/veterinary , Onchocerciasis/veterinary , Oxytetracycline/therapeutic use , Animals , Arsenicals/therapeutic use , Cattle , Female , Onchocerciasis/drug therapy , Time Factors , Triazines/therapeutic use
6.
Microbes Infect ; 8(12-13): 2698-705, 2006 Oct.
Article in English | MEDLINE | ID: mdl-16962357

ABSTRACT

Many filarial nematodes, including Onchocerca volvulus (the cause of human 'River Blindness'), have a mutually dependent relationship with Wolbachia bacteria. There has been much interest in Wolbachia as a chemotherapeutic target, since there are no macrofilaricidal drugs (i.e., lethal to adult worms) of low toxicity. Using the bovine parasite O. ochengi, we previously demonstrated that combined intensive and intermittent (COM) oxytetracycline treatment induces a sustained depletion of Wolbachia and is macrofilaricidal, whereas a short intensive regimen (SIR) is non-macrofilaricidal. To understand how targeting Wolbachia with oxytetracycline can lead to worm death, O. ochengi nodules (onchocercomata) were sequentially excised from cattle administered COM or SIR therapy, and cell infiltrates were microscopically quantified. Pre-treatment, worms were surrounded by neutrophils, with eosinophils rare or absent. At 8-12weeks after either regimen, eosinophils increased around worms and were observed degranulating on the cuticle. However, with the SIR treatment, neutrophils returned to predominance by 48weeks, while in the COM group, eosinophilia persisted. These observations suggest that accumulation of degranulating eosinophils over a prolonged period is a cause rather than an effect of parasite death, and the macrofilaricidal mechanism of antibiotics may relate to facilitation of eosinophil infiltration around worms by ablation of Wolbachia-mediated neutrophilia.


Subject(s)
Anti-Bacterial Agents/pharmacology , Eosinophils/immunology , Onchocerca/immunology , Onchocerca/microbiology , Onchocerciasis/immunology , Oxytetracycline/pharmacology , Wolbachia/drug effects , Animals , Anti-Bacterial Agents/therapeutic use , Cattle , Cell Degranulation , Histocytochemistry , Leukocyte Count , Onchocerciasis/drug therapy , Onchocerciasis/pathology , Oxytetracycline/therapeutic use , Symbiosis
7.
Proc Natl Acad Sci U S A ; 103(15): 5971-6, 2006 Apr 11.
Article in English | MEDLINE | ID: mdl-16585501

ABSTRACT

Onchocerciasis (river blindness) is a major parasitic disease of humans in sub-Saharan Africa caused by the microfilarial stage of the nematode Onchocerca volvulus. Using Onchocerca ochengi, a closely related species which infects cattle and is transmitted by the same black fly vector (Simulium damnosum sensu lato) as O. volvulus, we have conducted longitudinal studies after either natural field exposure or experimental infection to determine whether, and under what circumstances, protective immunity exists in onchocerciasis. On the basis of the adult worm burdens (nodules) observed, we determined that cattle reared in endemic areas without detectable parasites (putatively immune) were significantly less susceptible to heavy field challenge than age-matched, naïve controls (P = 0.002), whereas patently infected cattle, cured of infection by adulticide treatment with melarsomine, were fully susceptible. Cattle immunized with irradiated third-stage larvae were significantly protected against experimental challenge (100% reduction in median nodule load, P = 0.003), and vaccination also conferred resistance to severe and prolonged field challenge (64% reduction in median nodule load, P = 0.053; and a significant reduction in microfilarial positivity rates and density, P < 0.05). These results constitute evidence of protective immunity in a naturally evolved host-Onchocerca sp. relationship and provide proof-of-principle for immunoprophylaxis under experimental and field conditions.


Subject(s)
Onchocerciasis/immunology , Onchocerciasis/veterinary , Vaccines , Animals , Anthelmintics/therapeutic use , Cattle , Cattle Diseases/drug therapy , Cattle Diseases/epidemiology , Cattle Diseases/immunology , Disease Models, Animal , Onchocerca , Onchocerciasis/drug therapy , Onchocerciasis/epidemiology , Prevalence
8.
J Infect Dis ; 192(8): 1483-93, 2005 Oct 15.
Article in English | MEDLINE | ID: mdl-16170768

ABSTRACT

Development of a drug lethal to adult Onchocerca volvulus (i.e., macrofilaricide) is a research priority for the control of human onchocerciasis. Using bovine O. ochengi infections, we investigated the effects of oxytetracycline administered in a short intensive regimen (SIR; 10 mg/kg daily for 14 days), compared with a prolonged intermittent regimen (PIR; 20 mg/kg monthly for 6 months) or a combination of both (COM), on the viability of adult worms and their endosymbiotic bacteria (Wolbachia species). The long-term treatments eliminated >80% (COM) or >60% (PIR) of adult female worms (P<.001), and the COM regimen effected a sustained depletion of Wolbachia organisms. Conversely, SIR was not macrofilaricidal and only transiently depleted Wolbachia densities, which repopulated worm tissues by 24 weeks after treatment. These results unequivocally demonstrate the macrofilaricidal potential of tetracyclines against Onchocerca infection and suggest that intermittent, protracted administration will be more effective than continuous shorter term treatment.


Subject(s)
Cattle Diseases/parasitology , Onchocerca/microbiology , Onchocerciasis/drug therapy , Onchocerciasis/veterinary , Symbiosis/drug effects , Tetracyclines/pharmacology , Wolbachia/drug effects , Animals , Cattle , Cattle Diseases/drug therapy , Cattle Diseases/immunology , Disease Models, Animal , Tetracyclines/therapeutic use , Wolbachia/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...